Cargando…

Evaluation of Angiogenesis Assays

Angiogenesis assays allow for the evaluation of pro- or anti-angiogenic activity of endogenous or exogenous factors (stimulus or inhibitors) through investigation of their pro-or anti- proliferative, migratory, and tube formation effects on endothelial cells. To model the process of angiogenesis and...

Descripción completa

Detalles Bibliográficos
Autores principales: Stryker, Zachary I., Rajabi, Mehdi, Davis, Paul J., Mousa, Shaker A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631830/
https://www.ncbi.nlm.nih.gov/pubmed/31100863
http://dx.doi.org/10.3390/biomedicines7020037
_version_ 1783435610463141888
author Stryker, Zachary I.
Rajabi, Mehdi
Davis, Paul J.
Mousa, Shaker A.
author_facet Stryker, Zachary I.
Rajabi, Mehdi
Davis, Paul J.
Mousa, Shaker A.
author_sort Stryker, Zachary I.
collection PubMed
description Angiogenesis assays allow for the evaluation of pro- or anti-angiogenic activity of endogenous or exogenous factors (stimulus or inhibitors) through investigation of their pro-or anti- proliferative, migratory, and tube formation effects on endothelial cells. To model the process of angiogenesis and the effects of biomolecules on that process, both in vitro and in vivo methods are currently used. In general, in vitro methods monitor specific stages in the angiogenesis process and are used for early evaluations, while in vivo methods more accurately simulate the living microenvironment to provide more pertinent information. We review here the current state of angiogenesis assays as well as their mechanisms, advantages, and limitations.
format Online
Article
Text
id pubmed-6631830
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66318302019-08-19 Evaluation of Angiogenesis Assays Stryker, Zachary I. Rajabi, Mehdi Davis, Paul J. Mousa, Shaker A. Biomedicines Review Angiogenesis assays allow for the evaluation of pro- or anti-angiogenic activity of endogenous or exogenous factors (stimulus or inhibitors) through investigation of their pro-or anti- proliferative, migratory, and tube formation effects on endothelial cells. To model the process of angiogenesis and the effects of biomolecules on that process, both in vitro and in vivo methods are currently used. In general, in vitro methods monitor specific stages in the angiogenesis process and are used for early evaluations, while in vivo methods more accurately simulate the living microenvironment to provide more pertinent information. We review here the current state of angiogenesis assays as well as their mechanisms, advantages, and limitations. MDPI 2019-05-16 /pmc/articles/PMC6631830/ /pubmed/31100863 http://dx.doi.org/10.3390/biomedicines7020037 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Stryker, Zachary I.
Rajabi, Mehdi
Davis, Paul J.
Mousa, Shaker A.
Evaluation of Angiogenesis Assays
title Evaluation of Angiogenesis Assays
title_full Evaluation of Angiogenesis Assays
title_fullStr Evaluation of Angiogenesis Assays
title_full_unstemmed Evaluation of Angiogenesis Assays
title_short Evaluation of Angiogenesis Assays
title_sort evaluation of angiogenesis assays
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631830/
https://www.ncbi.nlm.nih.gov/pubmed/31100863
http://dx.doi.org/10.3390/biomedicines7020037
work_keys_str_mv AT strykerzacharyi evaluationofangiogenesisassays
AT rajabimehdi evaluationofangiogenesisassays
AT davispaulj evaluationofangiogenesisassays
AT mousashakera evaluationofangiogenesisassays